Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

RSYRT decoction

Phase 2Small molecule

PPeking University Cancer Hospital & Institute

1

Indications

1

Total Trials

0

Active Trials

0

Competitors

Clinical

Trials by Indication[1]

Fatigue1 trial

RSYR for Fatigue Reduction in Cancer Survivors

Completed·PPeking University Cancer Hospital & Institute·Phase 2·NCT03911921·92 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for RSYRT decoction. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — RSYRT decoction compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for RSYRT decoction. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Peking University Cancer Hospital & Institute company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: PPeking University Cancer Hospital & Institute

Related News